Cell Biotech Co Ltd
KOSDAQ:049960
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kao Corp
OTC:KAOOY
|
JP |
Cell Biotech Co Ltd
Total Current Assets
Cell Biotech Co Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cell Biotech Co Ltd
KOSDAQ:049960
|
Total Current Assets
₩103.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
|
Celltrion Inc
KRX:068270
|
Total Current Assets
₩6.2T
|
CAGR 3-Years
28%
|
CAGR 5-Years
20%
|
CAGR 10-Years
19%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Total Current Assets
₩1.2T
|
CAGR 3-Years
-11%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Total Current Assets
₩56.5B
|
CAGR 3-Years
45%
|
CAGR 5-Years
102%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Total Current Assets
₩480.8B
|
CAGR 3-Years
49%
|
CAGR 5-Years
28%
|
CAGR 10-Years
34%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Total Current Assets
₩176.1B
|
CAGR 3-Years
30%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Cell Biotech Co Ltd
Glance View
Cell Biotech Co., Ltd. engages in the manufacture, research and development of probiotics lactobacillus products. The company is headquartered in Gimpo, Gyeonggi-Do. The company went IPO on 2002-12-13. The firm's products include lactic acid bacteria (LAB) powders and finished products containing LABs. Its LAB powders are used as raw materials in foods and medicines for the functions of immunization enhancement and digestion improvement. Its finished products containing LABs are used for intestinal health improvement, carcinogen inhibition, calcium supplement and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Cell Biotech Co Ltd's Total Current Assets?
Total Current Assets
103.7B
KRW
Based on the financial report for Dec 31, 2025, Cell Biotech Co Ltd's Total Current Assets amounts to 103.7B KRW.
What is Cell Biotech Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
7%
Over the last year, the Total Current Assets growth was 7%. The average annual Total Current Assets growth rates for Cell Biotech Co Ltd have been 11% over the past three years , 10% over the past five years , and 7% over the past ten years .
